---
pmid: '29348145'
title: FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis
  and cell migration.
authors:
- Fung E
- Richter C
- Yang HB
- Schäffer I
- Fischer R
- Kessler BM
- Bassermann F
- D'Angiolella V
journal: EMBO Rep
year: '2018'
full_text_available: false
pmcid: PMC5836097
doi: 10.15252/embr.201744799
---

# FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration.
**Authors:** Fung E, Richter C, Yang HB, Schäffer I, Fischer R, Kessler BM, Bassermann F, D'Angiolella V
**Journal:** EMBO Rep (2018)
**DOI:** [10.15252/embr.201744799](https://doi.org/10.15252/embr.201744799)
**PMC:** [PMC5836097](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836097/)

## Abstract

1. EMBO Rep. 2018 Mar;19(3):e44799. doi: 10.15252/embr.201744799. Epub 2018 Jan
18.

FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and 
cell migration.

Fung E(1), Richter C(2)(3), Yang HB(1), Schäffer I(2)(3), Fischer R(4), Kessler 
BM(4), Bassermann F(5)(3), D'Angiolella V(6).

Author information:
(1)Department of Oncology, Cancer Research UK and Medical Research Council 
Institute for Radiation Oncology, University of Oxford, Oxford, UK.
(2)Department of Medicine III, Klinikum Rechts der Isar, Technische Universität 
München, München, Germany.
(3)German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 
Heidelberg, Germany.
(4)Nuffield Department of Medicine, Target Discovery Institute, University of 
Oxford, Oxford, UK.
(5)Department of Medicine III, Klinikum Rechts der Isar, Technische Universität 
München, München, Germany florian.bassermann@tum.de 
vincenzo.dangiolella@oncology.ox.ac.uk.
(6)Department of Oncology, Cancer Research UK and Medical Research Council 
Institute for Radiation Oncology, University of Oxford, Oxford, UK 
florian.bassermann@tum.de vincenzo.dangiolella@oncology.ox.ac.uk.

Aberrant centrosome organisation with ensuing alterations of microtubule 
nucleation capacity enables tumour cells to proliferate and invade despite 
increased genomic instability. CEP192 is a key factor in the initiation process 
of centrosome duplication and in the control of centrosome microtubule 
nucleation. However, regulatory means of CEP192 have remained unknown. Here, we 
report that FBXL13, a binding determinant of SCF (SKP1-CUL1-F-box)-family E3 
ubiquitin ligases, is enriched at centrosomes and interacts with the centrosomal 
proteins Centrin-2, Centrin-3, CEP152 and CEP192. Among these, CEP192 is 
specifically targeted for proteasomal degradation by FBXL13. Accordingly, 
induced FBXL13 expression downregulates centrosomal γ-tubulin and disrupts 
centrosomal microtubule arrays. In addition, depletion of FBXL13 induces high 
levels of CEP192 and γ-tubulin at the centrosomes with the consequence of 
defects in cell motility. Together, we characterise FBXL13 as a novel regulator 
of microtubule nucleation activity and highlight a role in promoting cell 
motility with potential tumour-promoting implications.

© 2018 The Authors.

DOI: 10.15252/embr.201744799
PMCID: PMC5836097
PMID: 29348145 [Indexed for MEDLINE]
